Document is current
Any future updates will be listed below
-
Authors
Lanius, Vivian https://orcid.org/0000-0002-3935-8187
Glocker, Barbara
Lösch, Christian https://orcid.org/0000-0003-3745-6442
Bratton, Daniel J. https://orcid.org/0000-0002-6135-0894
Callegari, Francesca
Wright, Melanie https://orcid.org/0000-0001-7931-3947
Rajamäki, Suvi
-
Funding
Funding for this research was provided by:
European Federation of Pharmaceutical Industries and Associations
GlaxoSmithKline
Novartis
- License Information
-
More Information
Article History
Received: 17 November 2024
Accepted: 5 June 2025
First Online: 11 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: VL and CL are full-time employees of UCB; CL holds shares in the company. BG and SR are full-time employees of Bayer. DJB is a full-time employee of GSK and holds shares in the company. FG and MW are full-time employees of Novartis; both hold shares in the company. The authors declare that they have no other competing interests.
